cellvie is pioneering Therapeutic Mitochondria Transplantation, a novel treatment approach aimed at the cellular energy metabolism. The first application will be in ischemia-reperfusion injury, specifically in kidney transplantation and heart attack patients, with the aim to develop a broad platform.
Products, services, technology
cellvie is pioneering Therapeutic Mitochondria Transplantation. The modality being used are mitochondria, the powerhouses of the cell. They are prepared and delivered using proprietary methods and systems, in order to re-invigorate the cell energy metabolism - e.g. in ischemia-distressed cells.
cellvie is open to collaborations in the field of Therapeutic Mitochondria Transplantation. These may include partnerships for co-development as well as licensing deals.